Akihiro Nakajima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Akihiro Nakajima has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
Sunao Nakamura
Department of Cardiology, Kawasaki Saiwai Hospital, Kawasaki City, Kanagawa, Japan
11 shared publications- Ik-Kyung Jang
Cardiology Division, Massachusetts General Hospital—Harvard Medical School, Boston, MA 02114, USA
7 shared publications Hang Lee
Biostatistics Center (H.L.), Massachusetts General Hospital, Harvard Medical School, Boston
6 shared publicationsIris McNulty
Cardiology Division (L.M.S., M.A., A.N., I.M., I.-K.J.), Massachusetts General Hospital, Harvard Medical School, Boston
5 shared publicationsOsamu Kurihara
Cardiovascular Center, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan (O.K.).
5 shared publications- Taishi Yonetsu
Department of Cardiovascular Medicine, Institute of Science Tokyo, Tokyo, Japan
5 shared publications
Latest Publications
- Open Access
- 18 March 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (11) , 107166
Digital Ischemia Following Radial Access Unmasking Systemic Sclerosis
- 18 March 2026
- Published by Elsevier in JACC: Case Reports
- Vol. 31 (11) , 107166
Open AccessDigital Ischemia Following Radial Access Unmasking Systemic Sclerosis
- 17 October 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (4) , 315
Optical coherence tomographic patterns of restenosis in patients treated with directional coronary atherectomy and drug-coated balloon therapy
Coronary stents are commonly used in current percutaneous coronary interventions. However, despite technological improvements in drug-eluting stents, limitations remain, including the occurrence of stent thrombosis, restenosis, and the requirement for long-term antiplatelet therapy after stenting. Combined treatment with directional coronary atherectomy (DCA) and drug-coated balloon (DCB) therapy is an alternative stent-less strategy.1 In our hospital, combined DCA and DCB treatment has been performed for suitable cases. Most cases had good patency with favourable healing without restenosis during the follow-up period. Conversely, three patients had clinically relevant restenosis 6 months after the intervention. Serial optical coherence tomography (OCT) images were obtained pre- and post-procedure, and 3 and 6 months after the intervention. In Patient 1, who had hypertension and dyslipidaemia, a large new layer with microvessels in the treated vessel wall was observed in OCT images at 6 months. In Patient 2, who had dyslipidaemia, new double layers with signal-poor voids were observed. These voids may be relatively large microvessels or signs of intraplaque haemorrhage. In Patient 3, who had hypertension and chronic kidney disease, a thick layer (already recognized in OCT images 3 months) developed. Additionally, elevated lipid levels were detected. These OCT findings in patients with restenosis suggest that the development of new layers due to unfavourable healing can be an important cause of restenosis after DCA and DCB therapy. Moreover, unfavourable healing can be affected by lipid levels, inflammation, and thrombogenicity. Our OCT findings also suggest that microvessels and intraplaque haemorrhage can be contributing factors to restenosis.
- 17 October 2023
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 45 (4) , 315
Optical coherence tomographic patterns of restenosis in patients treated with directional coronary atherectomy and drug-coated balloon therapy
Coronary stents are commonly used in current percutaneous coronary interventions. However, despite technological improvements in drug-eluting stents, limitations remain, including the occurrence of stent thrombosis, restenosis, and the requirement for long-term antiplatelet therapy after stenting. Combined treatment with directional coronary atherectomy (DCA) and drug-coated balloon (DCB) therapy is an alternative stent-less strategy.1 In our hospital, combined DCA and DCB treatment has been performed for suitable cases. Most cases had good patency with favourable healing without restenosis during the follow-up period. Conversely, three patients had clinically relevant restenosis 6 months after the intervention. Serial optical coherence tomography (OCT) images were obtained pre- and post-procedure, and 3 and 6 months after the intervention. In Patient 1, who had hypertension and dyslipidaemia, a large new layer with microvessels in the treated vessel wall was observed in OCT images at 6 months. In Patient 2, who had dyslipidaemia, new double layers with signal-poor voids were observed. These voids may be relatively large microvessels or signs of intraplaque haemorrhage. In Patient 3, who had hypertension and chronic kidney disease, a thick layer (already recognized in OCT images 3 months) developed. Additionally, elevated lipid levels were detected. These OCT findings in patients with restenosis suggest that the development of new layers due to unfavourable healing can be an important cause of restenosis after DCA and DCB therapy. Moreover, unfavourable healing can be affected by lipid levels, inflammation, and thrombogenicity. Our OCT findings also suggest that microvessels and intraplaque haemorrhage can be contributing factors to restenosis.
- 1 June 2022
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 15 (6) , e011612
Sex Differences in Culprit Plaque Characteristics Among Different Age Groups in Patients With Acute Coronary Syndromes
Background: Despite the significant decline in cardiovascular mortality in women over the past several decades, sex differences in the underlying pathology of acute coronary syndromes remain poorly understood. Previous postmortem studies have demonstrated sex differences in coronary plaque morphology with a higher prevalence of plaque erosion in young women and more plaque rupture in older women after menopause, whereas men showed no increase in prevalence of plaque rupture with age. However, in vivo data are limited. Methods: This study included patients who presented with acute coronary syndrome and underwent preintervention optical coherence tomography imaging of the culprit lesion. The culprit plaque was categorized as plaque rupture, plaque erosion or culprit plaque with calcification, and stratified by age. Features of plaque vulnerability at culprit lesion were also analyzed. Results: In 1368 patients (women=286), women and men had a similar distribution of culprit plaque morphology (plaque rupture versus plaque erosion). However, significant sex differences were found in the underlying mechanisms of acute coronary syndrome among different age groups: women showed a significant ascending trend with age in plaque rupture ( P P P =0.005), and microstructures including macrophages, cholesterol crystals, and calcification ( P =0.026). No trend was observed in men. Conclusions: Age related sex differences in culprit plaque morphology and vulnerability were identified in patients with acute coronary syndrome: prevalence of plaque rupture and vulnerability increased with age in women but not in men. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01110538 and NCT03479723.
- 1 June 2022
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 15 (6) , e011612
Sex Differences in Culprit Plaque Characteristics Among Different Age Groups in Patients With Acute Coronary Syndromes
Background: Despite the significant decline in cardiovascular mortality in women over the past several decades, sex differences in the underlying pathology of acute coronary syndromes remain poorly understood. Previous postmortem studies have demonstrated sex differences in coronary plaque morphology with a higher prevalence of plaque erosion in young women and more plaque rupture in older women after menopause, whereas men showed no increase in prevalence of plaque rupture with age. However, in vivo data are limited. Methods: This study included patients who presented with acute coronary syndrome and underwent preintervention optical coherence tomography imaging of the culprit lesion. The culprit plaque was categorized as plaque rupture, plaque erosion or culprit plaque with calcification, and stratified by age. Features of plaque vulnerability at culprit lesion were also analyzed. Results: In 1368 patients (women=286), women and men had a similar distribution of culprit plaque morphology (plaque rupture versus plaque erosion). However, significant sex differences were found in the underlying mechanisms of acute coronary syndrome among different age groups: women showed a significant ascending trend with age in plaque rupture ( P P P =0.005), and microstructures including macrophages, cholesterol crystals, and calcification ( P =0.026). No trend was observed in men. Conclusions: Age related sex differences in culprit plaque morphology and vulnerability were identified in patients with acute coronary syndrome: prevalence of plaque rupture and vulnerability increased with age in women but not in men. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01110538 and NCT03479723.
- 1 February 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 164, 27-33
Layered Plaque Characteristics and Layer Burden in Acute Coronary Syndromes
- 1 February 2022
- Published by Elsevier in The American Journal of Cardiology
- Vol. 164, 27-33
Layered Plaque Characteristics and Layer Burden in Acute Coronary Syndromes
- Open Access
- 5 October 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (19) , e020691
Age and Phenotype of Patients With Plaque Erosion
Background: A recent study reported that the outcome of patients with plaque erosion treated with stenting is poor when the underlying plaque is lipid rich. However, the detailed phenotype of patients with plaque erosion, particularly as related to different age groups, has not been systematically studied. Methods and Results: Patients with acute coronary syndromes caused by plaque erosion were selected from 2 data sets. Demographic, clinical, angiographic, and optical coherence tomography findings of the culprit lesion were compared between 5 age groups. Among 579 erosion patients, male sex and current smoking were less frequent, and hypertension, diabetes, and chronic kidney disease were more frequent in older patients. ST‐segment–elevation myocardial infarction was more frequent in younger patients. Percentage of diameter stenosis on angiogram was greater in older patients. The prevalence of lipid‐rich plaque (27.3% in age P P =0.027), and calcification (5.5% in age P <0.001) increased with age. After adjusting risk factors, younger patients were associated with the presence of thrombus, and older patients were associated with greater percentage of diameter stenosis and the presence of lipid‐rich plaque and calcification. Conclusions: The demographic, clinical, angiographic, and plaque phenotypes of patients with plaque erosion distinctly vary depending on age. This may affect the clinical outcome in these patients. Registration: URL: https://www.clinicaltrials.gov . Unique identifiers: NCT03479723, NCT02041650.
- 5 October 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (19) , e020691
Open AccessAge and Phenotype of Patients With Plaque Erosion
Background: A recent study reported that the outcome of patients with plaque erosion treated with stenting is poor when the underlying plaque is lipid rich. However, the detailed phenotype of patients with plaque erosion, particularly as related to different age groups, has not been systematically studied. Methods and Results: Patients with acute coronary syndromes caused by plaque erosion were selected from 2 data sets. Demographic, clinical, angiographic, and optical coherence tomography findings of the culprit lesion were compared between 5 age groups. Among 579 erosion patients, male sex and current smoking were less frequent, and hypertension, diabetes, and chronic kidney disease were more frequent in older patients. ST‐segment–elevation myocardial infarction was more frequent in younger patients. Percentage of diameter stenosis on angiogram was greater in older patients. The prevalence of lipid‐rich plaque (27.3% in age P P =0.027), and calcification (5.5% in age P <0.001) increased with age. After adjusting risk factors, younger patients were associated with the presence of thrombus, and older patients were associated with greater percentage of diameter stenosis and the presence of lipid‐rich plaque and calcification. Conclusions: The demographic, clinical, angiographic, and plaque phenotypes of patients with plaque erosion distinctly vary depending on age. This may affect the clinical outcome in these patients. Registration: URL: https://www.clinicaltrials.gov . Unique identifiers: NCT03479723, NCT02041650.
- Open Access
- 2 February 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (3) , e019235
Predictors for Rapid Progression of Coronary Calcification: An Optical Coherence Tomography Study
Background: The role of coronary calcification in cardiovascular events and plaque stabilization is still being debated, and factors involved in the progression of coronary calcification are not fully understood. This study aimed to identify the predictors for rapid progression of coronary calcification. Methods and Results: Patients with serial optical coherence tomography imaging at baseline and at 6 months were selected. Changes in the calcification index and predictors for progression of calcification were studied. Calcification index was defined as the product of the mean calcification arc and calcification length. Rapid progression of calcification was defined as an increase in the calcification index above the median value. Among 187 patients who had serial optical coherence tomography imaging, 235 calcified plaques were identified in 105 patients (56.1%) at baseline. After 6 months, the calcification index increased in 95.3% of calcified plaques from 132.0 to 178.2 ( P P P =0.037), lipid‐rich plaque (OR, 2.698; P =0.034), and macrophages (OR, 6.782; P P =0.003; macrophages; from 74.6% to 61.0%, P =0.001). Conclusions: Diabetes mellitus, chronic kidney disease, lipid‐rich plaque, and macrophages were independent predictors for rapid progression of coronary calcification. Baseline vascular inflammation and subsequent stabilization may be related to rapid progression of calcification. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01110538.
- 2 February 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (3) , e019235
Open AccessPredictors for Rapid Progression of Coronary Calcification: An Optical Coherence Tomography Study
Background: The role of coronary calcification in cardiovascular events and plaque stabilization is still being debated, and factors involved in the progression of coronary calcification are not fully understood. This study aimed to identify the predictors for rapid progression of coronary calcification. Methods and Results: Patients with serial optical coherence tomography imaging at baseline and at 6 months were selected. Changes in the calcification index and predictors for progression of calcification were studied. Calcification index was defined as the product of the mean calcification arc and calcification length. Rapid progression of calcification was defined as an increase in the calcification index above the median value. Among 187 patients who had serial optical coherence tomography imaging, 235 calcified plaques were identified in 105 patients (56.1%) at baseline. After 6 months, the calcification index increased in 95.3% of calcified plaques from 132.0 to 178.2 ( P P P =0.037), lipid‐rich plaque (OR, 2.698; P =0.034), and macrophages (OR, 6.782; P P =0.003; macrophages; from 74.6% to 61.0%, P =0.001). Conclusions: Diabetes mellitus, chronic kidney disease, lipid‐rich plaque, and macrophages were independent predictors for rapid progression of coronary calcification. Baseline vascular inflammation and subsequent stabilization may be related to rapid progression of calcification. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01110538.
- Open Access
- 5 January 2021
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 2021, 1-9
The Impact of Aortic Valvular Calcium on Transcatheter Heart Valve Distortion
Objectives. To investigate the relationship between the eccentric calcification of aortic valve and transcatheter heart valve (THV) distortion and the impact of THV distortion on echo parameters and clinical outcomes. Background. The effects of eccentric calcification of the aortic valve on the THV distortion and the relationship between THV distortion and clinical impact were not fully understood. Methods. Patients with symptomatic severe aortic stenosis who were undergoing THV implantation were enrolled. Patients underwent preprocedural, postprocedural multislice computed tomography (MSCT), and follow-up transthoracic echocardiogram (TTE). Delta calcium score (ΔCS) is defined as the difference between the maximum and minimal calcium scores of the three cusps, while valve distortion score (VDS) is defined as the difference between the longest and shortest stent frame, as obtained using MSCT. Patients were divided into two groups according to ΔCS: “noneccentric calcification group” and “eccentric calcification group.” Results. A total of 118 patients were enrolled (59 patients in noneccentric and 59 in eccentric calcification groups). VDS was significantly lower in the noneccentric calcification group than in the eccentric calcification group (1.31 ± 0.82 mm vs. 1.73 ± 0.76 mm, ). VDS was not associated with the degree of paravalvular leak (PVL) and aortic valvular mean pressure gradient (AVPG) at 30-day and 1-year follow-up TTE and the cumulative rates of all-cause death and rehospitalization at 2-year clinical follow-up. Conclusions. Eccentric valvular calcification was associated with longitudinal THV distortion. However, THV distortion was not associated with PVL, AVPG, and adverse clinical events during midterm follow-up.
- 5 January 2021
- Published by Wiley in Journal of Interventional Cardiology
- Vol. 2021, 1-9
Open AccessThe Impact of Aortic Valvular Calcium on Transcatheter Heart Valve Distortion
Objectives. To investigate the relationship between the eccentric calcification of aortic valve and transcatheter heart valve (THV) distortion and the impact of THV distortion on echo parameters and clinical outcomes. Background. The effects of eccentric calcification of the aortic valve on the THV distortion and the relationship between THV distortion and clinical impact were not fully understood. Methods. Patients with symptomatic severe aortic stenosis who were undergoing THV implantation were enrolled. Patients underwent preprocedural, postprocedural multislice computed tomography (MSCT), and follow-up transthoracic echocardiogram (TTE). Delta calcium score (ΔCS) is defined as the difference between the maximum and minimal calcium scores of the three cusps, while valve distortion score (VDS) is defined as the difference between the longest and shortest stent frame, as obtained using MSCT. Patients were divided into two groups according to ΔCS: “noneccentric calcification group” and “eccentric calcification group.” Results. A total of 118 patients were enrolled (59 patients in noneccentric and 59 in eccentric calcification groups). VDS was significantly lower in the noneccentric calcification group than in the eccentric calcification group (1.31 ± 0.82 mm vs. 1.73 ± 0.76 mm, ). VDS was not associated with the degree of paravalvular leak (PVL) and aortic valvular mean pressure gradient (AVPG) at 30-day and 1-year follow-up TTE and the cumulative rates of all-cause death and rehospitalization at 2-year clinical follow-up. Conclusions. Eccentric valvular calcification was associated with longitudinal THV distortion. However, THV distortion was not associated with PVL, AVPG, and adverse clinical events during midterm follow-up.
- Open Access
- 5 January 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (1) , e018205
Optical Coherence Tomography Predictors for a Favorable Vascular Response to Statin Therapy
Background: Specific plaque phenotypes that predict a favorable response to statin therapy have not been systematically studied. This study aimed to identify optical coherence tomography predictors for a favorable vascular response to statin therapy. Methods and Results: Patients who had serial optical coherence tomography imaging at baseline and at 6 months were included. Thin‐cap area (defined as an area with fibrous cap thickness multivariable analysis, baseline thin‐cap area (odds ratio [OR] 1.442; 95% CI, 1.024–2.031, P =0.036), macrophage index (OR, 1.031; 95% CI, 1.002–1.061, P =0.036), and layered plaque (OR, 2.767; 95% CI, 1.024–7.479, P =0.045) were identified as the significant predictors for a favorable vascular response. Favorable vascular response was associated with a decrease in the macrophage index. Conclusions: Three optical coherence tomography predictors for a favorable vascular response to statin therapy have been identified: large thin‐cap area, high macrophage index, and layered plaque. Favorable vascular response to statin was correlated with signs of decreased inflammation. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01110538.
- 5 January 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (1) , e018205
Open AccessOptical Coherence Tomography Predictors for a Favorable Vascular Response to Statin Therapy
Background: Specific plaque phenotypes that predict a favorable response to statin therapy have not been systematically studied. This study aimed to identify optical coherence tomography predictors for a favorable vascular response to statin therapy. Methods and Results: Patients who had serial optical coherence tomography imaging at baseline and at 6 months were included. Thin‐cap area (defined as an area with fibrous cap thickness multivariable analysis, baseline thin‐cap area (odds ratio [OR] 1.442; 95% CI, 1.024–2.031, P =0.036), macrophage index (OR, 1.031; 95% CI, 1.002–1.061, P =0.036), and layered plaque (OR, 2.767; 95% CI, 1.024–7.479, P =0.045) were identified as the significant predictors for a favorable vascular response. Favorable vascular response was associated with a decrease in the macrophage index. Conclusions: Three optical coherence tomography predictors for a favorable vascular response to statin therapy have been identified: large thin‐cap area, high macrophage index, and layered plaque. Favorable vascular response to statin was correlated with signs of decreased inflammation. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01110538.
- 1 November 2020
- Published by Elsevier in The American Journal of Cardiology
- Vol. 134, 48-54
Relation of Low-Density Lipoprotein Cholesterol Level to Plaque Rupture
- 1 November 2020
- Published by Elsevier in The American Journal of Cardiology
- Vol. 134, 48-54
Relation of Low-Density Lipoprotein Cholesterol Level to Plaque Rupture